Spectrophotometric Determination of Citalopram Hydrobromide in Pharmaceuticals

Authors

  • Badiadka Narayana Mangalore University
  • Kunnummel Veena Mangalore University

DOI:

https://doi.org/10.29356/jmcs.v54i2.952

Keywords:

Citalopram hydrobromide, spectrophotometry, bromatebromide mixture, thiocyanate, 1,10-phenanthroline

Abstract

Simple, rapid and sensitive methods are described for the spectrophotometric determination of citalopram hydrobromide (CIT) in pharmaceuticals. The method A is based on the oxidation of citalopram by a known excess of bromate-bromide mixture in hydrochloric acid medium, reduction of the residual oxidant by a fixed amount of iron(II) and the formation of iron(III)-thiocyanate-complex which is measured at 480 nm. In the method B, 1,10-phenanthroline is used as a complexing agent and the formation of iron(II)-1,10-phenanthroline, which is measured at 510 nm. The system obeys Beer’s law in the concentration range of 1.0-7.0 μg mL-1 of CIT for method A and 0.6-6.2 μg mL-1 of CIT for method B. No interference observed from common pharmaceutical adjuvants. Both methods are equally precise as shown by the relative standard deviation values less than 2%. The apparent molar absorptivities and Sandell’s sensitivity for method A and B are found to be 2.10x104 L mol-1 cm-1, 0.019 μg cm-2 , 7.30x104 L mol-1 cm-1 and 5.5x10-3 μg cm-2, respectively. The methods have been successfully applied to the determination of citalopram hydrobromide in pure and dosage forms.

Downloads

Download data is not yet available.

Author Biographies

Badiadka Narayana, Mangalore University

Department of Post Graduate Studies and Research in Chemistry

Kunnummel Veena, Mangalore University

Department of Post Graduate Studies and Research in Chemistry

References

1. Fuller, R.W. J. Clin. Psychiatry 1986, 47, 4-8
2. Baumann, P. Int. Clin. Psychopharmacol. 1996, 11, 5-11
3. Uhr, M.; Tontsch, A.; Namendorf , C.; Ripke, S.; Lucae, S.; Ising, M.; Dose, T.; Ebinger, M.; Rosenhagen, M.; Kohli, M.; Kloiber, S.; Salyakina, D.; Bettecken, T.; Specht, M.; Pütz, B.; Binder, E.B.; Müller-Myhsok, B.; Holsboer, F. Neuron. 2008, 57, 203-209
4. Keller, M. B. J. Clin. Psychiatry 2000, 61, 896-908
5. Karch, A. Lippincott’s Nursing Drug Guide. Philadephia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo: Lippincott Williams & Wilkins 2006.
6. http://www.umm.edu/altmed/articles/st-johns-000276.htm accessed Feb 27 2009
7. Gastpar, M.; Singer, A.; Zeller, K. Pharmacopsychiatry 2006, 39, 66-75
8. Akerman, K. K.; Jolkkonen, J.; Huttunen, H.; Penttila, I. Ther. Drug. Moni. 1998, 20, 25-29
9. Lacassie, E.; Gautier, J. M.; Marquet, P.; Rabatel, J. F.; Lachatre, G. J. Chromatogr. B. 2000, 742, 229-238
10. Lai, C.K.; Lee, I.; Au, K.M.; Chan, A.Y. M. Clin. Chem. 1997, 43, 312-320
11. Carlsson, B.; Norlander. J. Chromatogr. B. 1997, 702, 234-239
12. Trachta, G.; Schwarze, B.; Sagmuller, B.; Brehm, G.; Schneider, S. J. Mol. Struct. 2004, 693, 175-185
13. Frahnert, C.; Rao, M. L.; Grasmader, K. J. Chromatogr. B. 2003, 794, 35-47
14. Molander, P.; Thomassen, A.; Kristoffersen, L.; Greibrokk, T.; Lundanes, E. J.Chromatogr. B. 2001, 766, 77-87
15. Tournel G.; Houdret, N. ; Hedouin, V.; Deveaux, M.; Gosset, D.; Lhermitte, M. J. Chromatogr. B. 2001, 761, 147-158
16. Macek, J.; Ptacek, P.; Klima, J. J. Chromatogr. B. 2001, 755, 279285
17. Kosel, M.; Eap, C. B.; Amey, M.; Baumann, P. J. Chromatogr. B. 1998, 719, 234-238
18. Labat, L.; Deveaux, M.; Dallet, P.; Dubost, J.P. J .Chromatogr. B. 2002, 773, 17-23
19. Flores, J. R.; Nevado, J. J. B.; Salcedo, A. M. C.; Diaz, M. P. C. J. Sep. Sci. 2004, 27, 33-40
20. Andersen, S.; Halvorsen, S.; Pedersen- Bjergaard, K. E.; Ramussen, L.; Tanum H.; Refsum. J. Pharm. Biomed. Anal. 2003, 33, 263-273
21. Buzinkaiova, T.; Polonsky, J. J. Electrophoresis. 2000, 21, 28392841
22. Raza, A. Chem. Pharm. Bull. 2006, 54, 432-434

Downloads

Published

2019-06-17

Issue

Section

Regular Articles